The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Influenza Medication-Global Market Insights and Sales Trends 2024

Influenza Medication-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1859519

No of Pages : 99

Ask Your Query
Synopsis
Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
The global Influenza Medication market size is expected to reach US$ 742.9 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Influenza Medication in various end use industries. The expanding demands from the Hospitals, Clinics, Pharmacies and Others, are propelling Influenza Medication market. Zanamivir, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oseltamivir segment is estimated at % CAGR for the next seven-year period.
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Influenza Medication, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Influenza Medication market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Influenza Medication market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Influenza Medication sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Influenza Medication covered in this report include Daiichi Sankyo Company, GlaxoSmithKline, Natco Pharma, F. Hoffmann-La Roche, Teva Pharmaceutical, Sandoz International, Sun Pharmaceutical Industries and Mylan, etc.
The global Influenza Medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International
Sun Pharmaceutical Industries
Mylan
Global Influenza Medication market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Influenza Medication market, Segment by Type:
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Others
Global Influenza Medication market, by Application
Hospitals
Clinics
Pharmacies
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Influenza Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Influenza Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Influenza Medication Market Overview
1.1 Influenza Medication Product Overview
1.2 Influenza Medication Market Segment by Type
1.2.1 Zanamivir
1.2.2 Oseltamivir
1.2.3 Peramivir
1.2.4 Amantadine
1.2.5 Rimantadine
1.2.6 Inosine
1.2.7 Others
1.3 Global Influenza Medication Market Size by Type
1.3.1 Global Influenza Medication Market Size Overview by Type (2018-2029)
1.3.2 Global Influenza Medication Historic Market Size Review by Type (2018-2023)
1.3.3 Global Influenza Medication Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Influenza Medication Sales Breakdown by Type (2018-2023)
1.4.2 Europe Influenza Medication Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Influenza Medication Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Influenza Medication Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Influenza Medication Sales Breakdown by Type (2018-2023)
2 Global Influenza Medication Market Competition by Company
2.1 Global Top Players by Influenza Medication Sales (2018-2023)
2.2 Global Top Players by Influenza Medication Revenue (2018-2023)
2.3 Global Top Players by Influenza Medication Price (2018-2023)
2.4 Global Top Manufacturers Influenza Medication Manufacturing Base Distribution, Sales Area, Product Type
2.5 Influenza Medication Market Competitive Situation and Trends
2.5.1 Influenza Medication Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Influenza Medication Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Medication as of 2022)
2.7 Date of Key Manufacturers Enter into Influenza Medication Market
2.8 Key Manufacturers Influenza Medication Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Influenza Medication Status and Outlook by Region
3.1 Global Influenza Medication Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Influenza Medication Historic Market Size by Region
3.2.1 Global Influenza Medication Sales in Volume by Region (2018-2023)
3.2.2 Global Influenza Medication Sales in Value by Region (2018-2023)
3.2.3 Global Influenza Medication Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Influenza Medication Forecasted Market Size by Region
3.3.1 Global Influenza Medication Sales in Volume by Region (2024-2029)
3.3.2 Global Influenza Medication Sales in Value by Region (2024-2029)
3.3.3 Global Influenza Medication Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Influenza Medication by Application
4.1 Influenza Medication Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Pharmacies
4.1.4 Others
4.2 Global Influenza Medication Market Size by Application
4.2.1 Global Influenza Medication Market Size Overview by Application (2018-2029)
4.2.2 Global Influenza Medication Historic Market Size Review by Application (2018-2023)
4.2.3 Global Influenza Medication Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Influenza Medication Sales Breakdown by Application (2018-2023)
4.3.2 Europe Influenza Medication Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Influenza Medication Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Influenza Medication Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Influenza Medication Sales Breakdown by Application (2018-2023)
5 North America Influenza Medication by Country
5.1 North America Influenza Medication Historic Market Size by Country
5.1.1 North America Influenza Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Influenza Medication Sales in Volume by Country (2018-2023)
5.1.3 North America Influenza Medication Sales in Value by Country (2018-2023)
5.2 North America Influenza Medication Forecasted Market Size by Country
5.2.1 North America Influenza Medication Sales in Volume by Country (2024-2029)
5.2.2 North America Influenza Medication Sales in Value by Country (2024-2029)
6 Europe Influenza Medication by Country
6.1 Europe Influenza Medication Historic Market Size by Country
6.1.1 Europe Influenza Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Influenza Medication Sales in Volume by Country (2018-2023)
6.1.3 Europe Influenza Medication Sales in Value by Country (2018-2023)
6.2 Europe Influenza Medication Forecasted Market Size by Country
6.2.1 Europe Influenza Medication Sales in Volume by Country (2024-2029)
6.2.2 Europe Influenza Medication Sales in Value by Country (2024-2029)
7 Asia-Pacific Influenza Medication by Region
7.1 Asia-Pacific Influenza Medication Historic Market Size by Region
7.1.1 Asia-Pacific Influenza Medication Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Influenza Medication Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Influenza Medication Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Influenza Medication Forecasted Market Size by Region
7.2.1 Asia-Pacific Influenza Medication Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Influenza Medication Sales in Value by Region (2024-2029)
8 Latin America Influenza Medication by Country
8.1 Latin America Influenza Medication Historic Market Size by Country
8.1.1 Latin America Influenza Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Influenza Medication Sales in Volume by Country (2018-2023)
8.1.3 Latin America Influenza Medication Sales in Value by Country (2018-2023)
8.2 Latin America Influenza Medication Forecasted Market Size by Country
8.2.1 Latin America Influenza Medication Sales in Volume by Country (2024-2029)
8.2.2 Latin America Influenza Medication Sales in Value by Country (2024-2029)
9 Middle East and Africa Influenza Medication by Country
9.1 Middle East and Africa Influenza Medication Historic Market Size by Country
9.1.1 Middle East and Africa Influenza Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Influenza Medication Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Influenza Medication Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Influenza Medication Forecasted Market Size by Country
9.2.1 Middle East and Africa Influenza Medication Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Influenza Medication Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Daiichi Sankyo Company
10.1.1 Daiichi Sankyo Company Company Information
10.1.2 Daiichi Sankyo Company Introduction and Business Overview
10.1.3 Daiichi Sankyo Company Influenza Medication Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Daiichi Sankyo Company Influenza Medication Products Offered
10.1.5 Daiichi Sankyo Company Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Influenza Medication Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GlaxoSmithKline Influenza Medication Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Natco Pharma
10.3.1 Natco Pharma Company Information
10.3.2 Natco Pharma Introduction and Business Overview
10.3.3 Natco Pharma Influenza Medication Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Natco Pharma Influenza Medication Products Offered
10.3.5 Natco Pharma Recent Development
10.4 F. Hoffmann-La Roche
10.4.1 F. Hoffmann-La Roche Company Information
10.4.2 F. Hoffmann-La Roche Introduction and Business Overview
10.4.3 F. Hoffmann-La Roche Influenza Medication Sales, Revenue and Gross Margin (2018-2023)
10.4.4 F. Hoffmann-La Roche Influenza Medication Products Offered
10.4.5 F. Hoffmann-La Roche Recent Development
10.5 Teva Pharmaceutical
10.5.1 Teva Pharmaceutical Company Information
10.5.2 Teva Pharmaceutical Introduction and Business Overview
10.5.3 Teva Pharmaceutical Influenza Medication Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Teva Pharmaceutical Influenza Medication Products Offered
10.5.5 Teva Pharmaceutical Recent Development
10.6 Sandoz International
10.6.1 Sandoz International Company Information
10.6.2 Sandoz International Introduction and Business Overview
10.6.3 Sandoz International Influenza Medication Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sandoz International Influenza Medication Products Offered
10.6.5 Sandoz International Recent Development
10.7 Sun Pharmaceutical Industries
10.7.1 Sun Pharmaceutical Industries Company Information
10.7.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.7.3 Sun Pharmaceutical Industries Influenza Medication Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sun Pharmaceutical Industries Influenza Medication Products Offered
10.7.5 Sun Pharmaceutical Industries Recent Development
10.8 Mylan
10.8.1 Mylan Company Information
10.8.2 Mylan Introduction and Business Overview
10.8.3 Mylan Influenza Medication Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Mylan Influenza Medication Products Offered
10.8.5 Mylan Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Influenza Medication Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Influenza Medication Industrial Chain Analysis
11.4 Influenza Medication Market Dynamics
11.4.1 Influenza Medication Industry Trends
11.4.2 Influenza Medication Market Drivers
11.4.3 Influenza Medication Market Challenges
11.4.4 Influenza Medication Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Influenza Medication Distributors
12.3 Influenza Medication Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock